Zepzelca
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for Zepzelca, covering 2020-06-15 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer [Phase 2]